TP53 and amyotrophic lateral sclerosis: Furthermore, we confirmed significant increases in p53 pathway activity in ALS with both library preparations (polyA datasets: NES + 11.4, p < 0.001; Ribo-Zero datasets: NES + 7.3, p < 0.001; Supplementary Fig. 9e, f).